Trial intelligence / Profile preview

Phase II trial of oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab in high-risk rectal cancer

ISRCTN99828560Phase 2Completed

Sponsor

Royal Marsden NHS Foundation Trust

Start

Sep 2005

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules